Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAZEMETOSTAT for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 22 adverse event reports in the FDA FAERS database where TAZEMETOSTAT was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for TAZEMETOSTAT

Side Effect Reports % Deaths Hosp.
Disease progression 26 26.0% 3 1
Neutropenia 12 12.0% 6 3
Malignant pleural effusion 11 11.0% 0 1
Blood lactate dehydrogenase increased 10 10.0% 0 0
Drug ineffective 10 10.0% 5 3
Lymphadenopathy 10 10.0% 0 0
Off label use 10 10.0% 1 2
Myelodysplastic syndrome 8 8.0% 0 0
Thrombocytopenia 8 8.0% 0 1
Anaemia 7 7.0% 2 1
Fatigue 6 6.0% 0 3
Pneumocystis jirovecii infection 6 6.0% 6 2
Febrile neutropenia 5 5.0% 1 2
Nausea 5 5.0% 1 3
Vomiting 5 5.0% 1 4

Other Indications for TAZEMETOSTAT

Follicular lymphoma (31) Product used for unknown indication (11)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

TAZEMETOSTAT Full Profile All Diffuse large b-cell lymphoma Drugs TAZEMETOSTAT Demographics TAZEMETOSTAT Timeline